{
  "id": "5e2dfab2fbd6abf43b00001d",
  "type": "yesno",
  "question": "Does ProSavin use an adenoviral vector?",
  "ideal_answer": "No, ProSavin is a lentiviral vector based gene therapy.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/30156440"
  ],
  "snippets": [
    {
      "text": "Long-Term Follow-Up of a Phase I/II Study of ProSavin, a Lentiviral Vector Gene Therapy for Parkinson's Disease.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30156440",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "ProSavin, a lentiviral vector based gene therapy that delivers local and continuous dopamine, was previously shown to be well tolerated in a Phase I/II first-in-human study, with significant improvements in motor behavior from baseline at 1 year. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30156440",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}